Literature DB >> 6553016

Human tissue kallikrein. II. Isolation and characterization of human salivary kallikrein.

W Hofmann, A Junk, R Geiger.   

Abstract

Human salivary kallikrein was isolated from saliva using affinity chromatography on aprotinin-Sepharose and anti-human urinary kallikrein IgG-Sepharose followed by ion exchange chromatography on DEAE-Sepharose. The enzyme preparation had a specific activity of 950 U/mg protein towards the synthetic substrate Ac-Phe-Arg-OEt, a specific biological activity of 2000 KE/mg protein (measured in the dog blood pressure assay) and 0.64 HMW-kininogen-U/mg, corresponding to the liberation of 679 micrograms bradykinin equivalents per mg enzyme per min from HMW-kininogen (using the rat uterus test). In sodium dodecyl sulfate gel electrophoresis one protein band corresponding to a molecular mass of 32 kDa was obtained. The amino-acid composition was determined and isoleucin was found as the only N-terminal residue. The bimolecular velocity constant for the inhibition by diisopropyl fluorophosphate was determined as 8 l x mol-1 x min-1. The dissociation constant Ki of the human salivary kallikrein-aprotinin complex was calculated to be 0.7 x 10(-10)M. The Km and Vmax values for the hydrolysis of the synthetic substrates Ac-Phe-Arg-OEt and D Val-Leu-Arg-Nan were determined. In the enzyme immunoassay for human urinary kallikrein parallel binding curves were obtained.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6553016     DOI: 10.1515/bchm2.1983.364.1.425

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  2 in total

1.  New observations on the localization of kallikrein-like activity in human salivary parenchymal and mast cells by enzyme histochemistry.

Authors:  J R Garrett; A Kidd; K Kyriacou; R E Smith
Journal:  Histochem J       Date:  1984-07

2.  Activity-based mass spectrometric characterization of proteases and inhibitors in human saliva.

Authors:  Xiuli Sun; Erdjan Salih; Frank G Oppenheim; Eva J Helmerhorst
Journal:  Proteomics Clin Appl       Date:  2009-07-01       Impact factor: 3.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.